SUN PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 446.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 446.1%
Thu, 16 Aug

SUN PHARMA has announced its results for the quarter ended June 2018. Here is a detailed performance review of the same:

SUN PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-17*
3
Mar-18*
3
Jun-18*
QoQ ChangeYoY Change
Net SalesRs m62,08869,77172,2423.5%16.4%
Other incomeRs m1,5203,0281,998-34.0%31.4%
TurnoverRs m63,60872,79974,2392.0%16.7%
ExpensesRs m51,13152,93656,1756.1%9.9%
Gross profitRs m1,45216,83516,067-4.6%1006.9%
DepreciationRs m3,4664,5524,016-11.8%15.9%
InterestRs m1,0941,5541,309-15.8%19.6%
Profit before taxRs m-1,58913,75612,739-7.4%
TaxRs m1,618-1,7671,6391.3%
Profit after taxRs m-3,20715,52311,101-28.5%
Gross profit margin%2.324.122.2
Effective tax rate%-101.8-12.812.9
Net profit margin%-5.021.315.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 16.4% on a year-on-year (YoY) basis. The expenses were up by 9.9% YoY during the same period.
  • The company's operating profit increased by 1006.9% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 22.2% in 1QFY19 as against 2.3% in 1QFY18.
  • Depreciation charges and finance costs increased by 15.9% YoY and 19.6% YoY, respectively.
  • Other income increased by 31.4% YoY during the quarter.
  • Net profit for the quarter increased by 446.1% YoY. Net profit margins during the quarter increased from -5.0% in 1QFY18 to 15.0% in 1QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 3.5% on a quarter-on-quarter (QoQ) basis. The expenses were up by 6.1% QoQ during the same period.
  • The company's operating profit declined by 4.6% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 22.2% in 1QFY19 as against 24.1% in 4QFY18.
  • Net profit for the quarter declined by 28.5% QoQ, while net profit margins declined from 21.3% in 4QFY18 to 15.0% in 1QFY19.

To see how SUN PHARMA has performed over the last eight quarters, please visit here.

SUN PHARMA Share Price Performance

Over the last one year, SUN PHARMA share price has moved up from Rs 485.2 to Rs 615.5, registering a Gain of Rs 130.3 or around 26.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,813.1 (up 0.9%). Over the last one year it has moved up from 13,214.8 to 14,813.1, a gain of 1,598 points (up 12.1%).

Overall, the S&P BSE SENSEX is up 20.1% over the year.

Current Valuations

At the current price of Rs 615.5, the price to earnings (P/E) ratio of SUN PHARMA stands at 36.4 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 4.0 times.

Equitymaster requests your view! Post a comment on "SUN PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 446.1%". Click here!

  

Related Views on News

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, SUN PHARMA has posted a net profit of Rs 10 bn (down 29.8% YoY). Sales on the other hand came in at Rs 82 bn (up 5.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020(Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

What the RBI's Rate Cut Means for Options Traders(Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Which Stocks Should You Buy, Sell, and Hold in the Market Today?(Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

Why We Picked This Smallcap Stock for a Post Coronavirus World(Profit Hunter)

May 28, 2020

Covid-19 has made it a survival of the fittest race for many companies. The ones that can adapt will thrive in a post crisis world.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Jun 3, 2020 09:33 AM

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA - CADILA HEALTHCARE COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS